Acadia Pharmaceuticals (ACAD) Current Taxes (2022 - 2024)

Acadia Pharmaceuticals' Current Taxes history runs 3 years deep, the most recent figure standing at $8.5 million for Q2 2024.

• In Q2 2024, Current Taxes changed N/A year-over-year to $8.5 million; the TTM figure through Jun 2024 stood at $8.5 million (changed N/A YoY), while the FY2023 annual figure was $8.7 million, up 2210.34% from the prior year.
• Current Taxes was $8.5 million for Q2 2024 at Acadia Pharmaceuticals, up from $7.6 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $8.7 million in Q4 2023 to a low of $377000.0 in Q4 2022.
• Historically, Current Taxes has averaged $6.7 million across 3 years, with a median of $8.5 million in 2023.
• Biggest YoY gain for Current Taxes was 2210.34% in 2023; the steepest drop was 2210.34% in 2023.
• A 3-year view of Current Taxes shows it stood at $377000.0 in 2022, then soared by 2210.34% to $8.7 million in 2023, then dropped by 2.92% to $8.5 million in 2024.
• The last three Current Taxes figures came in at $8.5 million (Q2 2024), $7.6 million (Q1 2024), and $8.7 million (Q4 2023), per Business Quant data.